Author Page for Eric Donald Onyango

Artemether-Lumefantrine Versus Pyronaridine-Artesunate for the Treatment of Malaria in Patients with Mild to Moderate COVID-19 in Kenya and Burkina Faso: A Randomised Open-Label Trial (MALCOV)

Number of pages: 27 Posted: 04 Jun 2025

Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute, London School of Hygiene & Tropical Medicine, Kenya Medical Research Institute (KEMRI), Groupe de Recherche Action en Santé (GRAS), Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), London School of Hygiene & Tropical Medicine, Liverpool School of Tropical Medicine, London School of Hygiene & Tropical Medicine, Groupe de Recherche Action en Santé (GRAS), Groupe de Recherche Action en Santé (GRAS), Groupe de Recherche Action en Santé (GRAS), Groupe de Recherche Action en Santé (GRAS), Groupe de Recherche Action en Santé (GRAS), Groupe de Recherche Action en Santé (GRAS), London School of Hygiene & Tropical Medicine, London School of Hygiene & Tropical Medicine, London School of Hygiene & Tropical Medicine, Quantitative Engineering Design, Quantitative Engineering Design, Kenya Medical Research Institute (KEMRI) - Malaria Branch, Imperial College London, Ministry of Health, Burkina Faso - Centre National de Recherche et de Formation sur le Paludisme (CNRFP), London School of Hygiene & Tropical Medicine - Faculty of Infectious and Tropical Diseases and Kenya Medical Research Institute (KEMRI) - Malaria Branch

Downloads 106 (659,652)

Abstract:

2.

Chemoprevention for Malaria with Monthly Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Pregnant Women Living with HIV on Daily Cotrimoxazole in Kenya and Malawi: A Double-Blind, Randomised Placebo-Controlled Trial

Number of pages: 21 Posted: 13 Sep 2023

Hellen Cherono Barsosio, Mwayiwawo Madanitsa, Everlyne Delylah Ondieki, James Dodd, Eric Donald Onyango, Kephas Otieno, Duolao Wang, Jenny Hill, Victor Mwapasa, Kamija S. Phiri, Kenneth Maleta, Miriam Taegtmeyer, Simon Kariuki, Christenze Schmiegelow, Julie R. Gutman and Feiko O. ter Kuile

Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research, Kamuzu University of Health Sciences, Kenya Medical Research Institute (KEMRI), Liverpool School of Tropical Medicine - Department of Clinical Sciences, Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Liverpool School of Tropical Medicine - Department of Clinical Sciences, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Kamuzu University of Health Sciences, Liverpool School of Tropical Medicine, Kamuzu University of Health Sciences, Liverpool School of Tropical Medicine - Department of International Public Health, Kenya Medical Research Institute (KEMRI) - Malaria Branch, University of Copenhagen, Institute for Immunology and Microbiology, Centre for Medical Parasitology, Government of the United States of America - Centers for Disease Control and Prevention (CDC) and Kenya Medical Research Institute (KEMRI) - Malaria Branch

Downloads 52 (1,041,696)

Citation 1

Eric Donald Onyango

Kenya Medical Research Institute (KEMRI)

2

158

1

Scholarly Papers (2)

Artemether-Lumefantrine Versus Pyronaridine-Artesunate for the Treatment of Malaria in Patients with Mild to Moderate COVID-19 in Kenya and Burkina Faso: A Randomised Open-Label Trial (MALCOV)

Abstract:

Chemoprevention for Malaria with Monthly Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Pregnant Women Living with HIV on Daily Cotrimoxazole in Kenya and Malawi: A Double-Blind, Randomised Placebo-Controlled Trial

Abstract: